Transplant Diagnostics Market Forecast, Size, and Growth 2031

The Transplant Diagnostics Market size is projected to reach US$ 1,967.06 million by 2031 from US$ 1,070.65 million in 2023. The market is expected to register a CAGR of 7.90% in 2023–2031. The rising number of organ transplantation procedures globally, such as liver, kidney, heart, and lung transplants, is anticipated to propel the demand for transplant diagnostics, in turn boosting the overall market growth. Additionally, the growing prevalence of organ failure and chronic diseases demanding transplantation procedures is likely to remain key transplant diagnostics market trends.

Transplant Diagnostics Market Analysis

Transplantation is one of the most preferred treatment for patients suffering from renal disease and undergoing chronic dialysis therapy. It is also a viable choice considered in patients who are suffering from heart, or liver disease. Diagnostics across the world have improved significantly as companies have been developing better HLA typing technologies, antibody monitoring, instruments, and software. This technology is being used for diagnostics during organ transplantation. Advancement in transplant procedures offers a significant opportunity for market growth.

Transplant Diagnostics Market Overview

North America is the largest market for transplant diagnostics market growth with the US holding the largest market share followed by Canada. The growth in North America is characterized by the increasing number of organ transplants and, rising prevalence of organ failure in this region. According to data published in United Network for Organ Sharing.org, it is estimated that approximately 46,630 transplant procedures were carried out in the year 2023 in US. Similarly, according to donatelife.net in 2022, the US reached a historic milestone, accomplishing around 1 million organ transplants compared to any other country in the world. In 2023, more than 23,000 donors brought new life to recipients and their families. Moreover, approximately 100,000 people are on the waiting list for life-saving organ transplants. Thus, the rising number of organ transplants in the country is likely to drive market growth in the coming years.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Transplant Diagnostics Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Transplant Diagnostics Market Drivers and Opportunities

Rising Incidence of Chronic Ailments Requiring Organ Transplant Procedures Favors the Market

The rising need for organ transplants is supplemented by the escalating prevalence of chronic illnesses such as diabetes and kidney disease, which is further propelling the market for transplant diagnostics. For instance, according to the data published by the University of California San Francisco, around 750,000 patients in the United States and an estimated 2 million patients globally are affected by kidney failure every year.  Hence, with these organ failures, the need for donor kidneys in the US is also rising at 8% per year. Countries such as Japan, Taiwan, Mexico, the US, and Belgium hold the highest prevalence of kidney failure.

Integration of AI and Machine Learning– An Opportunity in the Transplant Diagnostics Market

A combination of artificial intelligence (AI) and machine learning algorithms has shown promising results in the transplant diagnostics market and can improve patient outcomes, speed up data analysis, and increase diagnostic accuracy which can result in market expansion. The demand for transplantation has been heightened due to various key factors, such as an aging population, the rising prevalence of chronic diseases, and advancements in medical devices that enable a wider range of patients to be eligible for transplantation.

Transplant Diagnostics Market Report Segmentation Analysis

Key segments that contributed to the derivation of the Transplant Diagnostics Market analysis are product and services, type, technology, and end users.

• Based on Products and Services, the Transplant Diagnostics market is segmented into Instruments, Reagents & Consumables, and Software & Services. Instruments, Reagents & Consumables, and Software & Services. The reagents and consumables held the largest share of the market in 2023. Software & Services witnessed the highest CAGR over the forecast period 2023-2031.
• By Type, the market is segmented into solid organ transplantation, Soft Tissue Transplantation, and Stem Cell Transplantation. The solid organ transplantation segment held the largest share of the market in 2023.
• By Technology, the market is segmented into Molecular Assays and Non-Molecular Assay. The molecular assay segment is expected to register the highest CAGR over the forecast period.
• By End User, the market is segmented into Hospitals & Transplant Centers, Research Laboratories & Academic Institutes, and Independent Reference Laboratories. The hospital and transplant centers segment held the largest share of the market in 2023.

Transplant Diagnostics Market Share Analysis by Geography

The geographic scope of the Transplant Diagnostics Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the Transplant Diagnostics Market. The market growth can be attributed to an increasing prevalence of organ failure and a rising number of organ donation along with organ transplant procedures is fueling the regional market growth. For instance, according to the data published by the Association of Organ Procurement Organizations (AOPO), a nonprofit organization in US states that in January 2021, more than 12,500 people donated one or more organs in 2020, and the number of organs donated from deceased donors increased to over 36,500 which is almost a 2% increase year over year. Moreover, organs from the dead have saved more than 33,000 lives in the past seven years.

Hence, rise in organ donation creates the need for increased transplant diagnostic testing and thus drives the growth of the market.

Transplant Diagnostics Market Regional Insights

The regional trends and factors influencing the Transplant Diagnostics Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Transplant Diagnostics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Transplant Diagnostics Market Market Report Scope

Market Players Density: Understanding Its Impact on Business Dynamics

The Transplant Diagnostics Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Transplant Diagnostics Market are:

1. Bio-Rad Laboratories,
2. Hologic,
3. Illumina, Inc.,
4. Thermo Fisher Scientific,
5. QIAGEN NV
6. Omixon, Inc.

Disclaimer: The companies listed above are not ranked in any particular order.

Transplant Diagnostics Market News and Recent Developments

The Transplant Diagnostics Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the Transplant Diagnostics market:

• Thermo Fisher Scientific added two new products to its transplant diagnostics portfolio during the American Society for Histocompatibility and Immunogenetics (ASHI) annual conference. (Source: Thermo Fisher Scientific, Press Release/Company Website/Newsletter, October 2023)
• Immucor, Inc., a company focused on transfusion and transplantation diagnostics, announced two additions to its transplant diagnostics portfolio, demonstrating its ongoing commitment to new advancements in the field of histocompatibility. (Source: Immucor, Press Release/Company Website/Newsletter, March 2022)
• Biocartis and Ophiomics entered into a collaboration to focus on the commercialization of HepatoPredict, a prognostic gene expression signature test to identify which patients will benefit from liver transplantation (Source: Biocartis, Press Release/Company Website/Newsletter, March 2022)

Transplant Diagnostics Market Report Coverage and Deliverables

The “Transplant Diagnostics Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles